Aryl hydrocarbon receptor (AhR) antagonists are compounds that inhibit the activation of AhR, a receptor involved in regulating immune and inflammatory responses. By blocking AhR's activity, these antagonists can modulate the immune system, making them potential candidates for treating various autoimmune and inflammatory conditions.